Coronavirus Covid-19 Information

TT Index

2023

  • January
    • Adverse drug reactions in older people in the community in Ireland
    • Thinking of a New Year’s resolution
    • Gynaecomastia
    • Glucocorticoid induced adrenal insufficiency (GC-AL)
    • Regular Updates
    • New Feature

 

2022

  • December
    • Thank you very much!
    • Morning versus evening antihypertensive medicine
    • Health Products Authority (HPRA) Update
    • Switching from a metered dose inhaler to a dry powder inhaler – effects on climate emissions and asthma control
    • Effectiveness of physical activity interventions delivered or prompted by healthcare professionals in primary care
    • NMIC Therapeutics Today 2022
  • November
    • The revised isotretinoin pregnancy prevention programme: awareness, knowledge & implementation in practice of healthcare professionals.
    • Risk of co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants.
    • Medicines Management Programme updates.
    • Effectiveness of preconception care interventions in primary care.
    • Paxlovid: update on prescribing and access
  • October
    • ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
    • HSE-Medicines Management Programme Update
    • Trends in direct oral anticoagulant prescribing in primary care in England
    • Gastrointestinal bleeding risk after concomitant treatment with non-vitamin K oral anticoagulants and oral glucocorticoids.
  • September
    • Obesity and oral emergency contraception
    • Recent journal Articles on pregnancy
    • Prescribing trends of antihypertensive medicines in the UK over 31 years
    • Health Products Regulatory Authority updates
    • HSeLanD Learning Module
  • August
    • Adverse drug reactions, multimorbidity and polypharmacy
    • Information resources for Ukrainian medicines
    • NMIC useful information resources webpage update
    • Medication Safety Minutes
    • Guideline update
  • July Supplement
    • Paxlovid : Update on prescribing and access
    • Key safety Points
    • Eligibility and prescribing considerations
    • Drug-drug interactions
    • Supply
  • July
    • Opioids versus non-opioids following surgical discharge
    • Further NMIC learning module on HSeLanD
    • Management of Gout
    • Guidance documents update
  • June
    • Serotonin Syndrome
    • Intramuscular injections in patients taking anticoagulant
    • Guideline updates
    • Drug reaction with eosinophilia and systemic symptoms (DRESS)
    • Use of medications that may raise blood pressure
  • May
    • Long-term nitrofurantoin therapy
    • Health Products Regulatory Authority updates
    • Guideline updates
    • Montelukast and neuropsychiatric reactions
    • Dose of paracetamol and low body weight
    • Factors to consider when using medicines following bariatric surgery
  • April
    • Sodium valproate (Epilim) utilisations trends in Ireland
    • Emollients and risk of burns
    • Non- vitamin K antagonist oral anticoagulants (NOACs) and pharmacokinetic drug interactions
    • Examples of medicines that should be prescribed by brand name
    • Guideline updates
    • NMIC CPD modules on contraception
    • Ukrainian Medicines Information Resources
  • March
    • Paxlovid and risk of drug interactions
    • Ireland’s second One Health National Action Plan (iNAP2) on Antimicrobial Resistance 2021-2025
    • Regular Updates
    • Measles
  • February
    • Overactive bladder (OAB) in women
    • Regular updates
    • Patient adherence, satisfaction and knowledge of direct oral anticoagulants (DOACs)
    • Impact of Gp-delivered medication review of older patients with multimorbidity and polypharmacy
  • January
    • Associations of Statins adherence and lipid targets with adverse outcomes in patients following myocardial infarction
    • Fatal adverse drug reactions
    • Childhood constipation

2021

  • December
    • NMIC publications 2021
    • Fruit and Vegetable intake and mortality
    • NMIC Clinical Enquiry Answering Service (CEAS)
    • Thinking about a new year’s resolution
    • Medicines Management Programme – Preferred Drugs
  • November
    • Gastrointestinal bleeding in older persons using aspirin
    • Domperidone and the risk of suddent cardiac death and ventricular arrhythmias
    • Bariatric Surgery and Oral Medicine Dosing
    • Regular NMCI Updates
  • October
    • Medication-related harm
    • Further NMIC learning module on HSeLand
    • Wrong dose medication incidents in a UK hospital
    • Dental implications of some commonly prescribed medicines
    • Regular NMIC updates
  • September
    • Medication adherence in cardiovascular disease
    • Medicines Management Programme (MMP) Update
    • Further NMIC learning module on HSeLanD!
    • Concurrent use of benzodiazepines and opioids and risk of hospitalisation and death
    • Supplements and risk of drug interactions
    • Regular Updates
  • August
    • Gabapentinoid and diuretic prescribing cascade
    • Medication Safety Minutes
    • Healthcare professionals’ awareness of Pregnancy Prevention Programme for sodium valproate (Epilim®) in Ireland
    • Update to Antibiotic Prescribing website
    • Health Products Regulatory Authority Updates
  • July
    • Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland;
    • NMIC useful medicines information resources webpage update
    • Poisoning related to medication errors with low-dose methotrexate
    • Potentially inappropriate prescribing in people in the community with chronic kidney disease
    • COVID-19 vaccine

  • June: 
    • Use of oral anticoagulants in elderly patients with atrial fibrillation
    • Postural hypotension
    • Recent Medication Safety Minutes
    • Recent Irish College of General Practitioners (ICGP) clinical guide
    • Health Products Regulatory Authority update regarding Vaxzevria®
    • Useful information and resources on COVID-19 vaccinations

  • May: 
    • Trends in strong opioid prescribing in Ireland
    • Pharmacist-led interventions to reduce adverse drug events in older people living in residential care facilities
    • Use of aspirin to prevent pre-eclampsia
    • HPRA Drug Safety Newsletter April 2021
    • Updated Guidelines
    • Further NMIC learning module on HSeLanD!
  • April: 
    • Drug-related deaths in European Hospitals
    • Comparison of interventions for reducing symptoms of depression in people with dementia
    • Bisphosphonate holidays
    • Recent Irish College of General Practitioners (ICGP) clinical guides
    • Reminder about CPD modules
    • Useful information and resources on COVID-19 vaccinations
  • March: 
    • Potentially inappropriate prescribing (PIP) in middle-aged adults
    • Medicines Management Programme (MMP) updates
    • Health Products Regulatory Authority (HPRA) Drug Safety Newsletter
    • Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19
    • Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain
    • Prescribing and sustainability - Irish Doctors for the Environment (IDE)
    • Useful information and resources on COVID-19 vaccines
    • NMIC bulletin on direct oral anticoagulants
    • Recent Irish College of General Practitioners (ICGP) clinical guide
  • February: 
    • Ten helpful hints to increase pharmacotherapy safety
    • Medicines Management Programme (MMP) Updates
    • Useful Information and Resources on COVID-19 vaccinations
    • Sodium-glucose contransporter protein-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1ra) for type 2 diabetes
    • Two NMIC learning modules on Drug Interactions are on HSELanD!

  • January: 
    • Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
    • HPRA Drug Safety newsletter 100th Edition!
    • Contraceptive use and fertility
    • Use of Z-drugs in people living with dementia
    • Resources available on COVID-19 vaccine